Merck
CN
  • Scutellariae radix induces apoptosis in chemoresistant SCC-25 human tongue squamous carcinoma cells.

Scutellariae radix induces apoptosis in chemoresistant SCC-25 human tongue squamous carcinoma cells.

The American journal of Chinese medicine (2015-02-03)
Byul-Bora Choi, Jeong Hae Choi, Sang-Rye Park, Ji-Young Kim, Jin-Woo Hong, Gyoo-Cheon Kim
摘要

Scutellariae radix is one of the most widely used anticancer herbal medicines in several Asian countries, including Korea, Japan, and China. Squamous cell carcinoma (SCC) is one of the most common head and neck carcinomas, which is highly invasive and metastatic, and can potentially develop chemoresistance. Therefore, new effective treatment methods are urgently needed. We determined the effects of Scutellariae radix on SCC-25 cells using the WST-1 assay, F-actin staining, flow cytometry analysis, immunofluorescence staining, and western blot analysis. Scutellariae radix treatment inhibited SCC-25 cell growth in a dose- and time-dependent manner, but it did not inhibit HaCaT (human keratinocyte) cell growth. Changes in cell morphology and disruption of filamentous (F)-actin organization were observed. Scutellariae radix-induced apoptosis as indicated by the translocation of cytochrome c and apoptosis-inducing factor (AIF) into the nucleus and cytosol. Scutellariae radix-induced an increase in cells with sub-G1 DNA content, and increased Bax, cleaved caspase-3, caspase-7, caspase-9, DNA fragmentation factor 45 (DFF 45), and poly(ADP-ribose) polymerase-1 (PARP-1) expression levels. Furthermore, increased expression of phosphorylated mitogen-activated protein kinase (MAPK)-related proteins was detected. The antitumor effect of Scutellariae radix was due to decreased cell proliferation, changes in cell morphology, and the activation of caspase and MAPK pathways. Taken together, the findings of this study highlight the anticancer activity of Scutellariae radix in chemoresistant SCC-25 oral squamous carcinoma cells.

材料
货号
品牌
产品描述

Sigma-Aldrich
二甲基亚砜, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
二甲基亚砜, for molecular biology
Sigma-Aldrich
二甲基亚砜, anhydrous, ≥99.9%
Sigma-Aldrich
二甲基亚砜, ACS reagent, ≥99.9%
Sigma-Aldrich
二甲基亚砜, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
二甲基亚砜, suitable for HPLC, ≥99.7%
Sigma-Aldrich
二甲基亚砜, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
二甲基亚砜, ReagentPlus®, ≥99.5%
Sigma-Aldrich
苯甲磺酰氟, ≥98.5% (GC)
Sigma-Aldrich
碘化丙啶, ≥94.0% (HPLC)
Sigma-Aldrich
二甲基亚砜, puriss. p.a., ACS reagent, ≥99.9% (GC)
Sigma-Aldrich
二甲基亚砜, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
二甲基亚砜, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
碘化丙啶 溶液
Sigma-Aldrich
5-氟脲嘧啶, ≥99% (HPLC), powder
Sigma-Aldrich
依托泊苷, synthetic, 95.0-105.0%, powder
Sigma-Aldrich
苯甲磺酰氟, ≥99.0% (T)
Sigma-Aldrich
碘化丙啶, ≥94% (HPLC)
Sigma-Aldrich
DL-甘油醛-3-磷酸 溶液, 45-55 mg/mL in H2O
Sigma-Aldrich
二甲基亚砜, puriss. p.a., dried, ≤0.02% water
Sigma-Aldrich
二甲基亚砜, PCR Reagent
Supelco
二甲基亚砜, analytical standard
USP
二甲基亚砜, United States Pharmacopeia (USP) Reference Standard
Supelco
氟尿嘧啶, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
二甲基亚砜, for inorganic trace analysis, ≥99.99995% (metals basis)
二甲基亚砜, European Pharmacopoeia (EP) Reference Standard
Supelco
5-氟脲嘧啶, analytical standard
依托泊苷, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
氟脲嘧啶, meets USP testing specifications
氟尿嘧啶, European Pharmacopoeia (EP) Reference Standard